Skip to main content
. 2019 Feb 6;7:31. doi: 10.1186/s40425-019-0502-7

Fig. 2.

Fig. 2

Long-term adverse outcomes of immune checkpoint inhibitor (ICI)-initiated pancreatic injury by discontinuation of ICI therapy and use of intravenous fluids